| http://dbpedia.org/ontology/abstract
|
4-Hydroxy-N-propyl-N-isopropyltryptamine (4-HO-PiPT, Piprocin) is a substituted tryptamine derivative which is claimed to have psychedelic effects. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/4-HO-PiPT_structure.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
71452109
|
| http://dbpedia.org/ontology/wikiPageLength
|
1536
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1115391946
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Substituted_tryptamine +
, http://dbpedia.org/resource/Category:Tryptamines +
, http://dbpedia.org/resource/4-HO-DiPT +
, http://dbpedia.org/resource/Canada +
, http://dbpedia.org/resource/Propylisopropyltryptamine +
, http://dbpedia.org/resource/4-HO-DSBT +
, http://dbpedia.org/resource/British_Columbia +
, http://dbpedia.org/resource/Ebalzotan +
, http://dbpedia.org/resource/4-HO-McPeT +
, http://dbpedia.org/resource/Designer_drug +
, http://dbpedia.org/resource/4-HO-McPT +
, http://dbpedia.org/resource/4-HO-DPT +
, http://dbpedia.org/resource/Psychedelic +
, http://dbpedia.org/resource/5-MeO-PiPT +
|
| http://dbpedia.org/property/c
|
16
|
| http://dbpedia.org/property/h
|
24
|
| http://dbpedia.org/property/iupacName
|
3
|
| http://dbpedia.org/property/n
|
2
|
| http://dbpedia.org/property/o
|
1
|
| http://dbpedia.org/property/smiles
|
CCNCCc1c[NH]c2ccccc21
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
CUTUPKOZXNFVHK-UHFFFAOYSA-N
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Tryptamines +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Tryptamines +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/4-HO-PiPT?oldid=1115391946&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/4-HO-PiPT_structure.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/4-HO-PiPT +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q113549019 +
, https://global.dbpedia.org/id/GPrdY +
, http://dbpedia.org/resource/4-HO-PiPT +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
4-Hydroxy-N-propyl-N-isopropyltryptamine (4-HO-PiPT, Piprocin) is a substituted tryptamine derivative which is claimed to have psychedelic effects. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.
|
| rdfs:label |
4-HO-PiPT
|
